Inapill

Currently in stealth, Inapill is developing novel therapeutics tuning immunometabolism to treat disease.

HQ location

Berkeley, United States

Launch date

Nov 2023

Employees

Get premium to view all results

Date	Investors	Amount	Round
-	investor	€0.0	round
Dec 2023	University of California, Berkeley	N/A	Spinout
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads